Clinical Trials Directory

Trials / Completed

CompletedNCT01370837

Neurogenic Inflammation in Diabetes

Neurogenic Inflammation in Diabetic Polyneuropathy and Charcot Neuro-osteoarthropathy: Response to Intracutaneous Candida Albicans

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Accepted

Summary

Polyneuropathy is a complication of diabetes mellitus which leads to decreased sensation in arms and legs. This in turn can lead to the development of (infected) foot ulcers. Charcot's disease can also be a consequence of polyneuropathy. Patients with Charcot's disease suddenly develop a red, warm and swollen foot, like an infection. Charcot's disease leads to foot fractures. After these fractures have healed, the shape of the foot can be dramatically altered. This altered shape of the foot increases the risk of developing foot ulcers. Nerves are important in regulating the inflammatory response. This study aims to investigate whether the inflammatory response is different in patients with polyneuropathy with and without a history of Charcot's disease.

Conditions

Interventions

TypeNameDescription
OTHERIntracutaneous injection of Candida albicans antigen.Intracutaneous injection of 0.05 ml of four different concentrations of Candida albicans antigen on both the arm and foot.
OTHERTemperature measurement.Temperature measurement at the site of injection of the highest concentration of Candida albicans antigen on the foot and the same location on the contralateral foot using an infrared thermometer.

Timeline

Start date
2012-05-01
Primary completion
2015-01-01
Completion
2015-01-01
First posted
2011-06-10
Last updated
2015-05-06
Results posted
2015-04-10

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01370837. Inclusion in this directory is not an endorsement.